Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
AMBUJACEM.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
+14%
4.31
vs 3.79
Q3.23
+1346%
3.74
vs 0.26
Q4.23
+91%
3.86
vs 2.02
Q1.24
+1%
3.83
vs 3.78
Q2.24
-39%
2.65
vs 4.31
Q3.24
-34%
2.48
vs 3.74
Q4.24
N/A
NA
vs 3.86
Q1.25
-13%
3.33
vs 3.83
Q2.25
+87%
4.96
vs 2.65
Q3.25
+57%
3.89
vs 2.48
Sales Growth
YoY
Current
Estimates
Q2.23
+8%
87.1B vs 80.3B
Q3.23
+4%
74.2B vs 71.4B
Q4.23
+3%
81.3B vs 79.1B
Q1.24
+12%
88.9B vs 79.7B
Q2.24
-5%
83.1B vs 87.1B
Q3.24
+1%
75.2B vs 74.2B
Q4.24
+4%
84.2B vs 81.3B
Q1.25
+10%
98B vs 88.9B
Q2.25
+22%
101B vs 83.1B
Q3.25
+30%
97.9B vs 75.2B
Return on Equity
QoQ
Q2.23
NA
NA
vs 1.62
Q3.23
+2%
0.02
vs NA
Q4.23
+2%
0.02
vs 0.02
Q1.24
+3%
0.03
vs 0.02
Q2.24
+1%
0.01
vs 0.03
Q3.24
+1%
0.01
vs 0.01
Q4.24
+4%
0.04
vs 0.01
Q1.25
+2%
0.02
vs 0.04
Institutionnal Ownership
Relative Strength
AMBUJACEM.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How AMBUJACEM.NS compares to sector?